ArticleTherapeutics and clinical risk management2017
Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference center.
Article in Therapeutics and clinical risk management, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 31 citations in OpenAlex.
- Occult cytomegalovirus infection presents anastomotic leakage after gastrectomy: Two case reports.Medicine · 2026Article
- A case of anti-glomerular basement membrane disease complicated by severe cytomegalovirus enteritis in a patient who survived after a prolonged ICU stay.CEN case reports · 2025Article
- Diagnostic performance of noninvasive tests for cytomegalovirus ileocolitis: a systematic review and meta-analysis.Intestinal research · 2025Article
- Case of Pseudomembranous Colitis Caused by aThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023Article
- Article
- Non-clostridium difficile induced pseudomembranous colitis.World journal of clinical cases · 2023Review
- Emergency gastrointestinal tract operation associated with cytomegalovirus infection.Annals of surgical treatment and research · 2023Article
- Cytomegalovirus enteritis: a surprising cause of severe diarrhoea and protein-losing gastroenteropathy in an intensive care patient.BMJ case reports · 2022Article
- Risk Factors, Clinical and Endoscopic Features, and Clinical Outcomes in Patients with Cytomegalovirus Esophagitis.Journal of clinical medicine · 2022Article
- Cytomegalovirus Diseases of the Gastrointestinal Tract.Viruses · 2022Article
- Polyarteritis Nodosa with Cytomegalovirus Enteritis and Jejunoileal Perforation: Report of a Case with a Literature Review.Vascular health and risk management · 2022Review
- Clinical manifestations, risk factors, and prognostic factors of cytomegalovirus enteritis.Gut pathogens · 2021Article
- Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.Scientific reports · 2021Article
- Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients.Gastroenterology research and practice · 2021Article
- Patient characteristics, clinical manifestations, prognosis, and factors associated with gastrointestinal cytomegalovirus infection in immunocompetent patients.BMC gastroenterology · 2020Article
- CMV Ileitis: To Treat or Not to Treat? Implications of Initiating Biologic Therapy for Concurrent Crohn's Disease.Case reports in gastrointestinal medicine · 2019Article
- Determining the optimal cutoff point for lymph node density and its impact on overall survival in children with Wilms' tumor.Cancer management and research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCytomegalovirus (CMV) colitis is considered rare in immunocompetent patients.
objectiveThe predictors of mortality and the differences between immunocompetent and immunocompromised patients with this disease remain unknown. Thus, the aim of this retrospective cohort study was to clarify these issues. PATIENTS AND
methodsWe enrolled all patients who were histologically diagnosed with CMV colitis between April 2002 and December 2016 in the Linkou Chang Gung Memorial Hospital. Patients were divided into two groups: immunocompetent and immunocompromised, and the differences between them were analyzed to develop in-hospital mortality predictors.
resultsA total of 69 patients (42, immunocompetent; 27, immunocompromised) were enrolled. The most common symptoms were melena in the immunocompetent group and diarrhea in the immunocompromised group. The in-hospital mortality rate showed no statistically significant difference between the two groups (26.2% vs 25.9%,
conclusionCMV colitis in immunocompetent patients is markedly more common and fatal than has generally been acknowledged. Being alert to different ways in which this disease can present itself will enable early diagnosis and significantly reduce mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.